Cytek Biosciences, Inc. (CTKB) investor relations documents from the company's IR site: 1 presentation, 16 press releases; latest deck 2025-02-27. Read in-app with summaries. First-party data.
Cytek Biosciences Fourth Quarter 2024 Earnings Conference Call Presentation — Cytek Biosciences reported FY 2024 revenue of $200.5 million, a 4% year-over-year increase, and an adjusted EBITDA of $22.4 million, up 77% year-over-year.
CTKB overview · CTKB earnings · CTKB financials · CTKB KPIs · CTKB ownership · CTKB peers · CTKB filings
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.